Literature DB >> 19067116

Anti-inflammatory and analgesic components from "hierba santa," a traditional medicine in Peru.

Marii Kawano1, Mayumi Otsuka, Kazuhiro Umeyama, Mikio Yamazaki, Tetsuo Shiota, Motoyoshi Satake, Emi Okuyama.   

Abstract

"Hierba santa," a Peruvian herbal medicine, is used to alleviate many symptoms, including headache, hemorrhoids, fever, and rheumatism. Several Cestrum species are said to be the origin of hierba santa. Three lots of hierba santa: Cestrum auriculatum (herb 1 and herb 2) and C. hediundinum (herb 3), which were purchased from Peruvian markets at Cuzco (Andes area) and Equitos (Amazon area), respectively, were examined for their pharmacological activities and active components. Herbs 1-3 showed anti-inflammatory and analgesic activities in the in vivo writhing inhibition test in mouse and inhibited prostaglandin E(1)-, E(2)-, or ACh-induced contractions of guinea pig ileum in the Magnus method. Activity-based separation of each extract yielded cestrumines A and B, cestrusides A and B, a mixture of (+)- and (-)-pinoresinol glucosides, nicotiflorin, rutin, sinapoyl glucose, ursolic acid, beta-sitosteryl glucoside, and 2-sec-butyl-4,6-dihydroxyphenyl-beta-D: -glucopyranoside. Among them, cestrumine A and cestrusides A and B are new compounds. All three lots of hierba santa do not contain exactly the same active components.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19067116     DOI: 10.1007/s11418-008-0302-8

Source DB:  PubMed          Journal:  J Nat Med        ISSN: 1340-3443            Impact factor:   2.343


  15 in total

1.  Biologically active constituents of Melaleuca leucadendron: inhibitors of induced histamine release from rat mast cells.

Authors:  T Tsuruga; Y T Chun; Y Ebizuka; U Sankawa
Journal:  Chem Pharm Bull (Tokyo)       Date:  1991-12       Impact factor: 1.645

2.  [On the lignan glucosides of Symplocos lucida].

Authors:  H Inouye; Y Takeda; H Nishimura
Journal:  Yakugaku Zasshi       Date:  1973-01       Impact factor: 0.302

3.  Steroidal saponins from the leaves of Cestrum sendtenerianum.

Authors:  M Haraguchi; Y Mimaki; M Motidome; H Morita; K Takeya; H Itokawa; A Yokosuka; Y Sashida
Journal:  Phytochemistry       Date:  2000-12       Impact factor: 4.072

4.  Investigations on the steroidal anti-inflammatory activity of triterpenoids from Diospyros leucomelas.

Authors:  M C Recio; R M Giner; S Máñez; J Gueho; H R Julien; K Hostettmann; J L Ríos
Journal:  Planta Med       Date:  1995-02       Impact factor: 3.352

5.  Separation of Leucas aspera, a medicinal plant of Bangladesh, guided by prostaglandin inhibitory and antioxidant activities.

Authors:  Samir Kumar Sadhu; Emi Okuyama; Haruhiro Fujimoto; Masami Ishibashi
Journal:  Chem Pharm Bull (Tokyo)       Date:  2003-05       Impact factor: 1.645

6.  Bioactivity studies on beta-sitosterol and its glucoside.

Authors:  Irene M Villaseñor; Jennifer Angelada; Arlyn P Canlas; Deborah Echegoyen
Journal:  Phytother Res       Date:  2002-08       Impact factor: 5.878

Review 7.  Pharmacology of oleanolic acid and ursolic acid.

Authors:  J Liu
Journal:  J Ethnopharmacol       Date:  1995-12-01       Impact factor: 4.360

8.  Pharmacologically active components of Todopon Puok (Fagraea racemosa), a medicinal plant from Borneo.

Authors:  E Okuyama; K Suzumura; M Yamazaki
Journal:  Chem Pharm Bull (Tokyo)       Date:  1995-12       Impact factor: 1.645

9.  Ursolic acid from Plantago major, a selective inhibitor of cyclooxygenase-2 catalyzed prostaglandin biosynthesis.

Authors:  T Ringbom; L Segura; Y Noreen; P Perera; L Bohlin
Journal:  J Nat Prod       Date:  1998-10       Impact factor: 4.050

10.  Traditional medicinal plant use in Northern Peru: tracking two thousand years of healing culture.

Authors:  Rainer W Bussmann; Douglas Sharon
Journal:  J Ethnobiol Ethnomed       Date:  2006-11-07       Impact factor: 2.733

View more
  1 in total

Review 1.  The globalization of traditional medicine in northern peru: from shamanism to molecules.

Authors:  Rainer W Bussmann
Journal:  Evid Based Complement Alternat Med       Date:  2013-12-28       Impact factor: 2.629

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.